Search

everythinglearnresearchcommunity

for

Search:↓

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

Regulatory T cells help heal skin wounds by reducing inflammation and promoting tissue repair.

Regulatory T cells adapt to different environments to control inflammation and support tissue repair.

Patients with Alopecia areata have fewer specific immune cells that normally regulate the immune system, which may contribute to the condition.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

The MAGE3 hypothesis for alopecia areata did not lead to a significant breakthrough.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Alopecia areata causes unpredictable hair loss, and more research is needed to fully understand and treat it effectively.

Using fat-derived stem cells with the drug meglumine antimoniate can help control skin disease and reduce parasites in mice with leishmaniasis.

CRAC channels are crucial for the development and function of specialized immune cells, preventing severe inflammation and autoimmune diseases.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

A humanized CXCL12 antibody may delay and treat alopecia areata by altering the immune response.

Immune cells affect hair growth and could lead to new hair loss treatments.

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

New imaging technology can show up to 40 different markers in hair loss tissue, helping to understand hair disease better.

Targeting regulatory T cells may help treat age-related diseases.

Targeting specific T cells may help treat alopecia areata.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Targeting Vδ1+T-cells may help treat alopecia areata.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Inflammation damages sweat ducts, causing sweat gland injury.

JAK inhibitors effectively and safely treat alopecia areata with few serious side effects.

Key genes linked to immune response are upregulated in hair follicles and skin tissues in chronic discoid lupus erythematosus.

Key genes linked to immune response are highly active in lupus-affected hair follicles.

Fucoidan reduces bone cell formation by affecting T-cell activity.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.